CTIC Stock: CTI BioPharma Corp. Stock Price, Analysis & Insights
Get live CTIC stock price $9.10, comprehensive CTI BioPharma Corp. stock analysis, charts, news, and expert forecast. Real-time CTIC stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inh...
Company Information
- CEO
- Adam R. Craig
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 127
Contact Information
- Website
- https://www.ctibiopharma.com
- Address
- 3101 Western Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for CTI BioPharma Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for CTI BioPharma Corp.
- ⚠Investors should consider how CTI BioPharma Corp. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.20B
P/E Ratio (TTM)
-16.84
Beta
0.83
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CTIC with peer companies:
- Price
- $17.81
- Market cap
- 491.06M
- Price
- $29.06
- Market cap
- 1.27B
- Price
- $2.34
- Market cap
- 1.14B
- Price
- $3.53
- Market cap
- 56.39M
- Price
- $10.25
- Market cap
- 39.59M
- Price
- $12.50
- Market cap
- 1.33B
- Price
- $9.50
- Market cap
- 925.93M
- Price
- $16.87
- Market cap
- 1.06B
- Price
- $11.13
- Market cap
- 994.04M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.